当前位置: X-MOL 学术Mol. Cell › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Targeting Glutamine Metabolism and PD-L1: A Novel Anti-tumor Pas de Deux
Molecular Cell ( IF 14.5 ) Pub Date : 2020-11-19 , DOI: 10.1016/j.molcel.2020.11.005
Maria I. Matias , Valérie Dardalhon , Naomi Taylor

In this issue of Molecular Cell, Byun et al. (2020) find that the dual targeting of glutamine metabolism and the PD-L1 checkpoint inhibitor augments anti-tumor immunity. Mechanistically, decreased glutamine availability attenuated S-glutathionylation of SERCA, resulting in an increase in cytosolic calcium, enhanced NF-κB activity, and upregulation of programmed death-ligand 1.



中文翻译:

瞄准谷氨酰胺代谢和PD-L1:一种新型的抗肿瘤双人舞

在本期《分子细胞》中,Byun等人。(2020)发现谷氨酰胺代谢和PD-L1检查点抑制剂的双重靶向增强了抗肿瘤免疫力。从机制上讲,降低的谷氨酰胺可利用性会削弱SERCA的S-谷胱甘肽化,从而导致细胞内钙的增加,NF-κB活性的增强以及程序性死亡配体1的上调。

更新日期:2020-11-19
down
wechat
bug